Emergent BioSolutions
EBS
#8133
Rank
NZ$0.64 B
Marketcap
NZ$12.58
Share price
3.67%
Change (1 day)
-28.29%
Change (1 year)

Emergent BioSolutions (EBS) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : NZ$1.38 Billion

According to Emergent BioSolutions 's latest financial reports the company's total liabilities are NZ$1.38 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Emergent BioSolutions - Total liabilities on balance sheet (from 2004 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31NZ$1.37 B-14.53%
2024-12-31NZ$1.60 B-13.37%
2023-12-31NZ$1.85 B-33.74%
2022-12-31NZ$2.80 B42.14%
2021-12-31NZ$1.97 B-0.98%
2020-12-31NZ$1.99 B8.21%
2019-12-31NZ$1.83 B1.26%
2018-12-31NZ$1.81 B717.05%
2017-12-31NZ$0.22 B-58.81%
2016-12-31NZ$0.53 B-2.13%
2015-12-31NZ$0.55 B12.1%
2014-12-31NZ$0.49 B194.12%
2013-12-31NZ$0.16 B12.7%
2012-12-31NZ$0.14 B-10.99%
2011-12-31NZ$0.16 B1.49%
2010-12-31NZ$0.16 B18.3%
2009-12-31NZ$0.13 B-11.86%
2008-12-31NZ$0.15 B17.93%
2007-12-31NZ$0.13 B-5.66%
2006-12-31NZ$0.14 B138.47%
2005-12-31NZ$59.39 M-8.08%
2004-12-31NZ$64.61 M
2002-12-31NZ$35.6 M-74.38%
2001-12-31NZ$0.13 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
NZ$206.05 B 14,813.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$156.48 B 11,225.51%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$105.21 B 7,514.93%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
NZ$6.82 M-99.51%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
NZ$18.61 M-98.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ$0.12 B-91.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$57.19 B 4,039.80%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel